Q32 Bio
QTTB
91 hedge funds and large institutions have $582M invested in Q32 Bio in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 12 closing their positions.
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
6% more funds holding
Funds holding: 86 → 91 (+5)
0% less ownership
Funds ownership: 4.61% → 4.6% (-0%)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
23% less capital invested
Capital invested by funds: $756M → $582M (-$174M)
65% less call options, than puts
Call options by funds: $329K | Put options by funds: $930K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$17.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$10.2M |
| 3 |
CAC
Cowen and Company
New York
|
+$8.11M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$5.51M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$3.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$20.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.33M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.1M |
| 4 |
BlackRock
New York
|
-$768K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$639K |
QTTB Hedge Fund Activity: Q1 2020 in Review
91 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2020, worth a combined $582M — down 23% from $756M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new QTTB positions and 12 closed out — a net gain of 7 holders — while 26 added to existing stakes and 29 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $17.2M. The largest seller was Deerfield Management, cutting an estimated $20.6M.
- 91 institutional investors held Q32 Bio (QTTB) as of Q1 2020, up from 86 in Q4 2019.
- Funds reported $582M of Q32 Bio stock for Q1 2020, down 23% quarter-over-quarter.
- 19 funds opened new Q32 Bio positions in Q1 2020 and 12 closed out, a net change of +7 holders.
- The largest Q32 Bio buyer in Q1 2020 was Vivo Capital, an estimated $17.2M added.
- The largest Q32 Bio seller in Q1 2020 was Deerfield Management, an estimated $20.6M sold.
Based on aggregated 13F filings for Q1 2020.